The Addition of Montelukast to Fluticasone in the Treatment of Perennial Allergic Rhinitis

Stopped early · Phase 4 · Has a placebo group

Conditions studied: Rhinitis, Allergic, Perennial

In brief

Some people with nasal allergy symptoms continue to have symptoms even after treatment with a nasal steroid spray. The purpose of this study is to see if these patients are helped by adding another medication (montelukast) to their treatment compared to placebo (a substance that looks like the active medication but does not contain the drug).

Key facts

Study ID
NCT00119015
Run by
University of Chicago
People needed
102
Starts
2005-07-01
Expected to finish
2009-01-01
Last updated by the study team
2014-02-28

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.